0
ARTICLE |

NEWER ASPECTS OF THE THERAPEUTICS OF VIOSTEROL (IRRADIATED ERGOSTEROL)

A. F. HESS, M.D.; J. M. LEWIS, M.D.; HELEN RIVKIN, M.A.
JAMA. 1930;94(24):1885-1889. doi:10.1001/jama.1930.02710500003002.
Text Size: A A A
Published online

In June, 1924, it was announced by Hess, and in September of the same year by Steenbock, that inert substances can be endowed with antirachitic potency by means of ultraviolet irradiation.1 Less than two years later, Windaus and Hess2 and Rosenheim and Webster3 shed further light on this subject by showing that it is ergosterol which undergoes this remarkable metamorphosis. During the short period which has followed, much has been learned and the advance has been steady and significant, but this aspect of pharmacology is so novel that it is not surprising that much remains to be explored and elucidated.

As is true of nutritional disorders in general, so of rickets the most important realm of therapeutics is that of prevention. With this goal in view we attempted the absolute prevention of rickets in sixty infants, from 4 to 12 months of age, by giving, in the

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs